In the co-seasonal ASIT regimen after allergy challenge, mice in the ISA-51 High dose group also showed significantly lower total IgE compared with the ISA-51 Low dose and commercial vaccine groups (Figure 2B). The gene discussed is IGHE; the disease is allergic disease.